LARGO, Fla., November 18, 2024--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

At close: December 10 at 4:00:02 PM EST ...

If you’re on the fence about investing in Glaukos Corporation or CONMED Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

CONMED Corporation CNMD is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Conmed Corp is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, ...

If you’re on the fence about investing in CONMED Corporation or Insulet Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...